Brimrose Technology together with Johns Hopkins Hospital is developing a sensing system to measure the oxygen levels of the fetus while the mother is in labor. The quick identification of low oxygen levels and rapid correction will dramatically reduce infant mortality and brain disease such as cerebral palsy.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Organization Type: Early-stage Startup (Seed)
Market Keywords: life-saving device, infant mortality, cerebral palsy